Alex Kim, MA., Elevar Therapeutics, Chief Executive Officer
Mr. Kim has 30 years experience in the pharmaceutical industry. Mr. Kim’s experience includes executive management, business development, product and technology licensing, strategic planning, fund raising and M&A activity.
Soo Whan Choi, PhD., Elevar Therapeutics, Chief Strategy Officer
Dr. Choi has over 25 years experience in the pharmaceutical industry. He is a successful corporate leader combining a strong background in business development, fundraising, M&A activity, and operations.
Mr. Gueth joined the Board of Directors as an independent member in 2018. He was previously a Managing Director of Burrill Securities, and since October 2014 has been serving as Managing Director of EVOLUTION Life Science Partners.
Wook Kim, HLB & Next Science, Managing Director
Mr. Kim joined the Board of Director in 2019. He is currently a Managing Director of HLB and Next Science, a Korea-based company. He has over 20 years’ experience in corporate financing. He was previously a director of E-Land Group with M&A and Global Financing activity.
Paul Chen, Advenchen Laboratories, Chief Executive Officer
Mr. Chen has over 36 years of experience in the pharmaceutical industry with hands-on experience from discovery to preclinical to clinical development. As an inventor, he has authored almost 30 patents covering novel compounds and derivatives, including rivoceranib (commonly known as apatinib).